Introduction. The use of thyroid hormone supplementation (THS) for donor optimization has
not been standardized and remains an area of academic investigation and clinical interest …

METHODS: All adults in the United Network for Organ Sharing (UNOS) database from
January 1, 2000, to March 1, 2021, were analyzed. Simple comparisons were made with t …

BACKGROUND Donor thyroid hormone (TH) supplementation therapy is widely used.
Recent reports suggested an increased risk of graft dysfunction in heart transplant (HTx) …

” Expand the donor pool” has been the mantra of the transplant community for decades. In
recent years, hepatitis C donor heart use and technology that supports donation after …

Objective The effect of thyroid dysfunction on adverse outcomes has been studied in many
different patient populations. The objective of this study was to investigate the effect of …

Background Acute hypothyroidism after brain death results in hemodynamic impairments
that limit availability of donor hearts. Thyroid hormone infusions can halt that process and …

The year 2023 was record-breaking for organ donation and transplantation, including a
record for heart transplants in the United States (4,545). 1 The donor pool was notable for an …

Objective Heart transplantation (HT) is uniquely associated with the potential impact of
thyroid hormone therapy at three intersecting levels—donor, operation, and recipient. We …

Objectives To investigate whether recipient administration of thyroid hormone (liothyronine
[T3]) is associated with reduced rates of primary graft dysfunction (PGD) after orthotopic …

Background Heart transplant recipients suffer from depletions in triiodothyronine, despite the
absence of thyroid dysfunction, which may contribute to delayed graft function. Little is …